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Abstract
Biomineralization is a process of creating crystalline structures under biological 
control. The process takes place in hard tissues, such as bones, cartilages, and teeth. 
Biominerals are a combination of a crystal phase deposited onto an organic matrix. 
Inorganic components are mainly responsible for the biomineral hardness, while 
the organic matrix controls the shape, size, and polymorph of the crystals. Within 
the organic matrix, proteins exhibit a special biomineralization activity. Among 
them, one can distinguish insoluble collagen and soluble noncollagenous proteins. It 
is particularly noteworthy that noncollagenous proteins are intrinsically disordered 
proteins. High flexibility, acidic nature, and susceptibility to modifications make 
them especially adapted to the biomineralization control. This review paper is dedi-
cated to the proteins which are involved in biomineralization of bones and teeth.
Keywords: biomineralization, bones, teeth, SIBLINGs, intrinsically disordered proteins, 
collagen
1. Introduction
Biomineralization is a process of formation of an inorganic solid within the biologi-
cal system [1]. Biominerals are organic-inorganic composites, which fulfill various bio-
logical functions. In vertebrates, hard tissues provide body support, take part in tearing 
food, protect organs, and are reservoirs of calcium and phosphate. Understanding of 
molecular basis of biomineralization is essential to obtain new biomaterials.
Human hard tissues are formed of calcium orthophosphates [2]. Among them, 
most important are amorphous calcium phosphate, octacalcium phosphate, calcium 
hydrogenphosphate dihydrate, and calcium-deficient apatite and hydroxyapatite 
(HA) [3]. In organisms, calcium orthophosphates occur mainly in the form of 
poorly crystallized nonstoichiometric sodium-, magnesium-, and carbonate-
containing HA—so-called biological apatite [2–5].
Biomineralization is a multistep process, which requires using the structures of 
extracellular matrix vesicles, numerous enzymes and glycoproteins. Due to strict 
control, biominerals differ from pure chemical minerals [6]. In contrast to geologi-
cal minerals, biominerals are composite materials comprised of both inorganic 
and bioorganic components. The mineral constituent gives tissues hardness and 
resistance to mechanical damage. Stiffness of the tissue depends on the amount of 
inorganic components and organic phase [7]. About 70% of bone tissue is made up 
of mineral structure, while the rest is water and organic substances [1]. Moreover, 
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having formed in vivo under well-controlled conditions, biomineral phases often 
have properties, such as shape, size, crystallinity, isotopic, and trace element 
compositions, quite unlike their inorganically formed counterparts [2].
The key factors, which determine the size, shape, internal structure and properties 
of biominerals, are proteins, which control the nucleation and growth of the crystals. 
Biomineralization involves protein-protein interactions and interactions between 
proteins and inorganic fraction. Among them, two major groups can be distinguished. 
Scaffold for a growing mineral phase provides insoluble collagen. In human bones, 
collagen makes up to 20–30% wt. Nucleation and crystal growth regulation are 
controlled by soluble, noncollagenous proteins. They are usually highly acidic [8, 9], 
undergo extensive posttranslational modifications [10], and frequently belong to the 
group of intrinsically disordered proteins (IDPs) [11]. IDPs are dynamic, flexible, 
heterogeneous populations of molecules without a well-defined folded structure. 
The highly charged character, along with the low content of hydrophobic amino 
acid residues, results in strong electrostatic repulsion and the lack of a well-packed 
hydrophobic core [12]. High content of IDPs’ carboxyl and phosphate acidic groups 
involved in biomineralization results in high calcium binding capabilities. Examples 
of proteins engaged in bones and teeth biomineralization are shown in Table 1.
2.  The basic division of proteins involved in the formation of calcium 
phosphate biominerals
Bone and teeth biomineralization takes place within the extracellular matrix 
(ECM), outside the cells. ECM is a highly organized and complex structure, unique 
to the specific organ type. It is an organic, noncellular fraction of mineralized 
tissues, composed of structural and functional proteins [14]. The content of the 
organic fraction varies depending on the type of tissue and constitutes 30% of 
bone, 20–25% of dentin, and only 0.5% of mature enamel. The basic division of 
proteins involved in the formation of calcium phosphate biominerals includes 
insoluble matrix like collagen and soluble noncollagenous proteins (NCPs).
2.1 Collagenous proteins of ECM
Among organic phase components, there are insoluble substances, which 
include structural macromolecules, creating a scaffold for the growing mineral. 






Osteopontin AAA59974.1 4.4 ~34 70%
Bone sialoprotein AAA60549.1 4.1 ~35 59%
Matrix extracellular 
phosphoglycoprotein
AAK70343.1 8.6 ~58 64%
Dentin matrix protein-1 AAC51332.1 4.0 ~56 90%
Dentin sialophosphoprotein 
(preproprotein)
NP_055023.2 3.6 ~131 88%
Ameloblastin AAG35772.1 4.9 ~48 58%
Amelogenin AAC21581.1 6.5 ~22 65%
Bioinformatic predictions of a disordered structure in proteins were done with PONDR predictor (http://www.pondr.com/) [13].
Table 1. 
Proteins involved in bone and teeth biomineralization.
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They give shape to the resulting crystal and can act as initiators for the creation 
of crystallization roots. An example of such substance is collagen. Animal tissues 
primarily contain collagen type I or collagen type II [15]. Collagen is the major ECM 
molecule that self-assembles into cross-striated fibrils, provides support for cell 
growth, and is responsible for the mechanical resilience of connective tissues. The 
term “collagen” defines a whole family of glycoproteins. The most common motifs 
in the amino acid sequence of collagen are repeating sequence [Gly-X-Y]n, both 
with and without interruptions. The X and Y positions are occupied by proline and 
its hydroxylated form, hydroxyproline, respectively. The right-handed triple helix is 
formed from three left-handed polyproline α-chains of identical length, which gives 
collagen a unique quaternary structure [16]. Hydroxylation of the rest of the proline 
in collagen is necessary for the stabilization of the triple helix [17]. Collagen chains 
create interactions leading to the organization of chains in a four-stage array [18]. 
Collagen fibers are also cross-linked via lysyl residues [19]. Electron microscopy 
techniques allow to observe successive regions of overlap and gaps, resulting from 
the mutual arrangement of collagen fibers [20].
2.2 Noncollagenous proteins (NCPs) of extracellular matrix (ECM)
While structural collagen is the main protein of ECM, NCPs are important for 
the regulation of biomineralization. NCPs are usually acidic, capable of binding 
large amounts of calcium ions. Proteins, which directly influence biomineraliza-
tion, act as nucleators and regulators of crystal growth and orientation [21]. NCPs 
are frequently posttranslationally modified, e.g., phosphorylated, glycosylated, 
or proteolytically processed. A large number of noncollagenous proteins have 
disordered secondary and tertiary structures and belong to a group of intrinsically 
disordered proteins [11].
3.  Intrinsically disordered proteins in calcium phosphate 
biomineralization
IDPs are a group of proteins that have gained a special interest of research-
ers for over 20 years [12, 22, 23]. Their discovery was especially challenging for 
traditional protein structure paradigm, stating that protein function depends on 
a fixed tertiary structure. The IDP group includes proteins with altered second-
ary and tertiary structures from total random coil structure to some intrinsically 
disordered regions. They are characterized by considerable plasticity, flexibility, 
and high conformational dynamics. IDP features are high net charge and low 
hydrophobicity, which is not conducive to the formation of the hydrophobic core. 
They often bind low molecular ligands and macromolecules such as ions and 
proteins. By interacting with ligands, IDPs can undergo local or global structur-
ing. They can also fulfill their functions while remaining completely disordered. 
Other characteristics of this group are multiple amino acid repeats and suscepti-
bility to posttranslational modifications. An open structure and lack of a packed 
core increase the availability of potential phosphorylation, glycosylation, and 
proteolytic cleavage sites [24].
Extended, flexible structure, highly acidic nature, susceptibility to modifica-
tions and especially the ability to interact with many different partners make 
these proteins particularly adapted to the biomineralization control. Many NCPs 
belong to IDP group. Family of small integrin-binding ligand N-linked glycoprotein 
(SIBLING) is the example of IDPs engaged in HA formation and is presented below. 
In addition to SIBLINGs, enamel matrix proteins such as ameloblastin, amelotin, 
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and enamelin also have disordered structures [25]. More information about the pro-
teins involved in HA biomineralization belonging to IDPs can be found in reviews 
[11, 25, 26].
3.1 SIBLINGs
An example of NCPs is the family of small integrin-binding ligand N-linked 
glycoprotein (SIBLING). It is a group of proteins identified in bone, dentine, and 
cementum, which includes osteopontin (OPN), bone sialoprotein (BSP), dentin 
matrix protein-1 (DMP1), dentin sialophosphoprotein (DSPP), and matrix extracel-
lular phosphoglycoprotein (MEPE) [27]. It is believed that they all evolved as a result 
of gene duplication from extracellular calcium-binding phosphoprotein family. 
Although proteins differ in composition of amino-acid sequence, SIBLINGs share 
common features [28]. Their genes are located in a 375 kb region on the 4q21 human 
and 5q mouse chromosomes. They display a similar exon structure. Their sequence 
contains an Arg-Gly-Asp (RGD) motif, which mediates cell attachment/signaling by 
binding to cell-surface integrins [28]. SIBLINGs belong to IDP group and are highly 
acidic. They share numerous sequence repeats, which are often observed in the case 
of IDPs [26]. Particularly important for their biomineralization activity may be 
acidic serine- and aspartate-rich motifs (ASARM), which are involved in the phos-
phate administration [29, 30]. SILBINGs are frequently posttranslationally medi-
cated. Some of their biological functions depend on phosphorylation, glycosylation, 
proteolytic processing, sulfonation, or transglutaminase cross linking [31].
3.1.1 Osteopontin
Osteopontin (OPN), also known as secreted phosphoprotein 1 (SSP1), is a 
highly phosphorylated and glycosylated sialoprotein. It is a multifunctional protein 
expressed by several cell types including osteoblasts, osteocytes, as well as osteo-
clasts or odontoblasts [32]. OPN undergoes many posttranslational modifications 
such as phosphorylation, glycosylation, sulfonation, or proteolytic processing, and 
modifications vary depending on a protein role and localization [31]. In bones and 
dentin, osteopontin is located at the site of biomineral formation. Synthesis of OPN 
is stimulated by calcitriol, physiologically active form of vitamin D, which is known 
as a trigger for bone destruction and remodeling [33, 34].
Osteopontin was originally identified as a bridge between the cell and HA in 
ECM of bone [35]. It is known that OPN increases the adhesion of bone cells by con-
centrating in mineralized collagen matrix during bone formation and remodeling 
[36, 37]. The protein is highly produced by developing osteoblasts and osteoclasts, 
and it has been shown to regulate both cell type adhesions.
Another role of ONP during biomineralization is modulation of osteoclastic 
function. OPN binding to integrin αvβ3 is essential for regulation of osteoclastic 
activity and is necessary in the formation of a sealing zone [34]. Through CD44-
associated cell signaling, OPN stimulates osteoclast migration [38].
As a highly acidic phosphoprotein, OPN binds to the surface of hydroxyapatite 
crystals through the electrostatic interactions between crystals and carboxyl and 
phosphate groups. Furthermore, disordered structure of OPN can promote the 
binding of calcium ions. The results of in vitro and in vivo studies suggest that osteo-
pontin has an inhibitory effect on HA formation and growth [39, 40]. OPN knock-
out mice display increased mineral content and size [41]. Therefore, it is suggested 
that OPN is one of the proteins whose role is to prevent crystal formation in soft 
tissues. Peptides of OPN obtained after proteolytic processing differ in a biomin-
eralization effect. ASARM peptide of OPN binds to HA crystals and consequently 
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inhibits ECM matrix mineralization [42]. Its inhibition activity is dependent on 
serine residues’ phosphorylation. N- and C-terminal fragments of OPN from milk 
promote de novo HA formation, but at the same time, the central fragment showed 
an inhibitory effect [43].
3.1.2 Bone sialoprotein
Bone sialoprotein (BSP) is one of the most abundant NCPs of bone. In contrast 
to OPN, BSP is only localized in tissues that undergo mineralization: bone, dentin 
and mineralizing cartilage, and cementum [44]. The protein is produced by osteo-
blasts, osteocytes, osteoclasts, as well as by chondrocytes. Disordered structure of 
BSP was shown by NMR, CD, and SAXS studies [28, 45–47]. BSP is highly glycosyl-
ated especially at C-terminal fragment, and to a lesser extent also phosphorylated 
and sulfonated [31]. N-terminal region of the protein contains collagen-binding 
motif. In vivo and in vitro studies indicated that BSP can be involved in initial stages 
of hydroxyapatite biomineralization [48]. BSP is intensely expressed by osteoblastic 
cells in sites of primary bone formation. The protein is present at mineralizing 
boundaries of bone, dentin, and calcifying cartilage tissues. On the other hand, 
BSP increases osteoclastogenesis, and in that way, it can initiate bone remodeling. 
BSP knockout mice are characterized by short, hypomineralized bones with high 
trabecular bone mass [49, 50]. Overexpression of BSP leads to dwarfism, decreased 
bone mineral density, and decreased trabecular bone volume [51].
It was shown that BSP has high affinity to hydroxyapatite and acts as a de novo 
nucleator of HA crystals in vitro [52]. The protein also binds to type I collagen, and 
by interaction with collagen, BSP could regulate HA nucleation [53]. Moreover, 
control of mineral formation is highly associated with the state of phosphorylation, 
sulfonation, and glycosylation of BSP [27, 54, 55].
When creating skull bones, including the mandible, alveoli, and skull vault, the 
osteoprogenitor cells secrete a collagen extracellular matrix—osteoid. Skull bones 
are formed by intracerebral ossification. BSP affects biomineralization of the matrix 
in the ossification process, hence, the formation, shaping, and growth of hydroxy-
apatite crystals. In the absence of BSP, bone formation is delayed and osteoblast 
activity is impaired [56].
3.1.3 Matrix extracellular phosphoglycoprotein
Matrix extracellular phosphoglycoprotein (MEPE) is located in mineralized 
tissues as bone and dentin, but was found also in nonmineralized organs. The pro-
tein is primarily expressed by osteoblasts and osteocytes that are embedded within 
the mineralized matrix in bone and by odontoblasts during odontogenesis [57]. 
Similar to osteopontin, MEPE seems to be a multifunctional ECM protein. Results 
of in vivo and in vitro studies suggest that MEPE is important for bone mineral-
ization, Pi homeostasis and cell attachment [58–60]. The protein was originally 
identified as interacting with PHEX. PHEX by binding to MEPE protects the 
protein from proteolytic cleavage by cathepsin B. Cleavage by cathepsin B leads to 
the release of the ASRAM peptide. The ASRAM motif is a functional domain of 
MEPE responsible for its inhibitory activity [61]. The peptide may be responsible 
for phosphate and calcium regulation during the mineralization process. ASARM 
peptide inhibits hydroxyapatite mineralization by binding free calcium with high 
avidity, and their inhibitory effect is highly dependent on serine residues phos-
phorylation. AC100, another MEPE fragment, containing the integrin binding 
(RGD) and glycosaminoglycan-attachment (SGDG) motifs stimulates new bone 
formation in vitro and in vivo [62].
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3.1.4 Dentin matrix protein-1
Dentin matrix protein-1 (DMP1) was the first molecule identified by cloning 
from the dentin matrix. Besides dentin, the protein is located also in bone and 
cementum as well as in other nonmineralized tissues [63–65]. It is remarkably acidic 
and is a hydrophilic protein with many serine, aspartate, and glutamate residues. 
The protein is characterized by disordered structure that can aggregate in the pres-
ence of calcium ions [66].
It was shown that DMP1 is essential for both odontoblasts and osteoblasts matu-
ration. The protein controls odontogenesis, osteogenesis, and Pi homeostasis. The 
effect of DMP1 on HA biomineralization depends on posttranslational modifica-
tions. It was shown that phosphorylated DMP1 inhibits HA formation and growth, 
while the dephosphorylated form acts as a HA nucleator [67, 68].
It was demonstrated that DMP1 is proteolytically processed into N-terminal 
37-K fragment and 57-K fragment from the C-terminal region, and it is likely that 
full-length DMP1 is a precursor to these functional fragments [69]. It seems that the 
57-K fragment plays a key role in the biomineralization process. The 57-K fragment 
contains 41 phosphate groups, while the 37-K fragment has only 12 phosphate 
groups. In addition, the 57-K fragment contains many functional sequences and 
domains such as the RGD motif [70], the ASARM peptide [71], and the peptide 
functioning as nucleator [72, 73]. In contrast to the full-length DMP1, the 57-K 
fragment promoted HA nucleation and growth [66]. Furthermore, it was shown 
that DMP1 N-terminal fragment is able to stabilize the metastable amorphous 
calcium phosphate. Due to high aspartic acid residual content, the 37-K fragment 
can bind calcium ions very strongly favoring formation and stabilization of the 
amorphous nuclei [72]. It was shown that the DMP1 57-K fragment also controls 
calcium carbonate mineralization in vitro [74].
3.1.5 Dentin sialophosphoprotein
Dentin sialophosphoprotein (DSPP) was discovered by cDNA cloning using a 
mouse odontoblast cDNA library and was the first believed to be connected only 
with dentin. Subsequent studies have revealed that the protein is expressed also 
in bone, cementum, and some nonmineralized tissues [75, 76]. Analysis of DSPP 
knockout mice and mutation in the DSPP gene indicated a special role of protein in 
dentin mineralization. In humans, a mutation in the DSPP gene causes dentin hypo-
mineralization and significant tooth decay, named dentinogenesis imperfecta [77]. 
Additionally, studies of DSPP-null mice suggest that DSPP is crucial in the initial 
mineralization of bone as well as in the remodeling of the skeleton and therefore on 
bone turnover [78].
It is suggested that DSPP is a precursor protein activated after proteolytic pro-
cessing. Cleavage of DSPP by zinc metalloproteinase bone morphogenetic protein-1 
(BPM1) results in two protein fragments: dentin phosphoprotein (phosphophoryn) 
(DPP) and dentin sialoprotein (DSP) [79]. Subsequently, cleavage of C-terminal 
of DSP by matrix metalloproteinase 2 (MMP2) and MMP20 leads to the release of 
the third fragment called dentin glycoprotein (DGP), which has a strong affinity to 
hydroxyapatite [80].
Highly acidic DPP is the most abundant NCP of ECM in dentin. Amino acid 
sequence of DPP is composed mainly of aspartic acid and serine residues, whereas 
~80% of serine residues are phosphorylated and phosphorylation is crucial to its 
function. The protein is also glycosylated [81] and contains ASARM peptide. Due 
to its amino acid composition and phosphorylation, DPP binds large amounts of 
calcium ions with high affinity. The protein is involved in nucleation and control of 
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the formation and growth of HA crystals during dentin mineralization [82, 83]. DPP 
binds to collagen fibrils and is present in front of dentin mineralization [84, 85]. 
There is a hypothesis that in front of mineralization, DPP is promoting the forma-
tion of initial apatite crystals [86]. When predentin is converted to dentin, DPP with 
other proteins binds to the growing HA faces and inhibits or slows down crystal 
growth [86–88].
4. Other proteins specific to teeth or bones
4.1 Tooth
Dentin, enamel, and cementum are calcified tissues and are major components 
of teeth. Dentin is usually covered by enamel on the crown and cementum on 
the root and surrounds the entire pulp. About 70% (wt) of dentin consists of the 
mineral phase, 20% (wt) is an organic material, and 10% (wt) is water. Enamel is 
the hardest substance in the human body and contains 96% (wt) of mineral phase. 
Enamel and dentin are created by two layers, namely odontoblasts and ameloblasts. 
Dentin is characterized by a high content of collagen I comprising ~90% of the 
dentin organic matrix [89].
4.1.1 Enamel
The organic part of enamel consists mainly of hydrophobic proteins, known 
as amelogenins and anionic proteins, which include ameloblastin, enamelin, and 
tuftelin [90]. Enamel also contains sialophosphoproteins and enamel proteases 
such as matrix-20 metalloproteinase (MMP-20, matrix metalloproteinase-20, also 
known as enamelysin) and kallikrein 4 (KLK4). At the end of the crystallization, 
enamel loses almost entire organic matrix, which is degraded and replaced by 
hydroxyapatite crystals [90]. Residues, small peptides, and amino acids account for 
only 1% of enamel and do not resemble the original matrix [90].
Amelogenins are a group of heterogeneous proteins present in odontoblasts 
and identified in enamel of maturing teeth. They are the main proteins of the 
organic enamel matrix, constituting over 90% of the pool of proteins secreted 
by ameloblasts into the intercellular matrix during the formation of enamel. 
These are hydrophobic proteins rich in proline, glutamine, leucine, and histidine. 
Amelogenins isolated from various organisms are characterized by high homol-
ogy [91]. Amelogenins belong to IDP groups; conformational analysis by CD and 
NMR spectroscopy showed that recombinant porcine amelogenin rP172 exists in an 
extended, unfolded state in the monomeric form [92]. The extended, labile con-
formation of rP172 amelogenin is compatible with known functions of amelogenin 
in enamel biomineralization, i.e., self-assembly, associations with other enamel 
matrix proteins and with calcium phosphate biominerals, and interaction with cell 
receptors [92].
Amelogenin controls the organization and growth of enamel crystals, and its 
presence is critical for normal enamel formation. Defects in amelogenin sequence 
lead to defective enamel crystal formation and organization [93].
Ameloblastin, also known as amelin, is a tooth-specific glycoprotein. Unlike 
amelogenin, ameloblastin is located close to the cell surface [94]. Ameloblastin 
accounts for about 5–10% of all proteins present in the enamel, and it is the sec-
ond most abundant protein among the intercellular matrix of the enamel [95]. 
Ameloblastin is also synthesized in dentin and cement, but its role in these tissues is 
not determined. Ameloblastin is a molecule of cell adhesion required to maintain a 
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diversified state of ameloblasts [96]. Bioinformatic analyzes and molecular model-
ing of the protein structure suggest that it may belong to IDPs [97], which was 
confirmed by the CD spectra of recombinant mouse protein [98].
The N-terminal fragment of ameloblastin comprising the self-assembly motif 
was shown to colocalize with amelogenin across the entire growing enamel, indi-
cating the role of the two proteins in the organization of the linear growth of HA 
crystallites [99–101]. Both proteins self-assemble into higher order structures from 
monomeric subunits, similar to type I collagen, the predominant matrix protein of 
bones, and dentin [102, 103]. Full-length amelogenin undergoes hierarchical step-
wise assembly, first forming oligomers, which in turn assemble into higher order 
structures and stabilize mineral prenucleation clusters, and organize them into 
parallel arrays of linear chains, yielding the formation of crystallite bundles [102]. 
There is a hypothesis that the higher order structures of the self-assembled amelo-
blastin (or most likely its N-terminal moiety) contribute to the oriented growth of 
the linear chains of amelogenin in the 3D space [104].
4.1.2 Dentin
Dentin forms a support for hard tissues of a tooth. It covers both crown and root 
structures and is responsible for its shape. The formation of dentin is closely related 
to bone. Both bone and dentin are composed of a collagenous matrix and a mineral 
phase with hydroxyapatite plate-like crystals. Mineralization of dentin and bone 
extracellular matrix is initiated with the aid of matrix vesicles and later involves 
secretion of families of a specialized matrix protein [105]. In contrast to bones, 
dentin is not remodeled and does not participate in the regulation of calcium and 
phosphate metabolism. The tooth formation takes place throughout the lifetime of a 
tooth. Unlike enamel, dentin mineral content increases with age due to continuous 
mineral deposition either as physiological secondary dentin or as tertiary dentin 
following injury [105].
Dentin is composed of a collagen I, which accounts for about 92% of organic 
components. In addition to collagen, there is also a group of noncollagen proteins, 
which include dentin-specific phosphoryls (DPPs) and dentin sialoproteins (DSP), 
sialic acid, osteopontin, dentin matrix proteins (DMP1, DMP2, DMP3), BSP, acidic 
bone-75 glycoprotein, osteonectin, and proteins rich in γ-carboxyglutamic acid. 
Among organic components should also be mentioned proteoglycans, growth fac-
tors, phospholipids, and enzymes [106, 107]. Inorganic dentin components make up 
to about 70% of the tissue mass, making the dentin harder than the bone. The mass 
of a single hydroxyapatite crystal is about 10 times greater than in bone, but many 
times less than in enamel, and its size is about 35 × 10 × 100 nm [108].
4.1.3 Cementum
Cementum protects the dental root dentin with a very thin layer. In many 
respects, it is very unique: it is not vascularized and is not innervated, it does 
not undergo constant remodeling like a bone, but it grows all the time. Cellular 
and acellular cement are distinguished based on the presence of cementocytes 
in its structure. The structure and composition of cement resembles bone tissue. 
Inorganic constituents make up to about 65% of tissue mass and consist mainly of 
hydroxyapatite crystals [109, 110].
Cementum provides contact between roots of the teeth and periodontium 
ligaments [111]. hrCEMP1 (recombinant human cementum protein 1) is an isolated 
form of cementum human β-sheet protein. It has been showed that hrCEMP1 
forms clusters of 6.5 nm diameter [111]. hrCEMP1 is an inducer of specific 
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biomineralization proteins. It stimulates the differentiation of osteoblasts and 
cementoblasts. It is suggested that hrCEMP1 plays a significant role in octacalcium 
phosphate biomineralization and helps its binding to hydroxyapatite even without 
posttranslational modifications. X-ray diffraction measurements showed that 
hrCEMP1 is an inducer of polymorphic crystals [111].
4.2 Bone
The matrix of bone consists of type I collagen molecule self-assembled into 
a triple helix consisting of two α1 and one α2 chains (ca. 300 nm in length and 
1.5 nm in diameter) and hydroxyapatite (Ca10(PO4)6(OH)2) nanocrystals (plate-
shaped, 1.5–4 nm in thickness) deposited along collagen fibrils [112, 113]. The 
collagen fiber does not undergo spontaneous mineralization in the presence of 
phosphate and calcium ions [20], and the involvement of noncollagen proteins is 
necessary. The majority of these proteins belong to the SIBLING family described 
above [27].
Bones and dentin are characterized by a similar composition and the mechanism 
of their formation [112]. Their organic matrix consists of type I collagen and the 
mineral matrix built of hydroxyapatite. Osteoblasts and odontoblasts, cells involved 
in osteogenesis and dentinogenesis, first secrete a nonmineralized matrix—a bone 
osteoid, and in case of dentin—predentin and then with fibers of collagen I form 
matrix for biomineralization [112]. Calcium and phosphate ions are dislocated 
from the vascular network into the mineralization matrix. Osteoid and predentin 
contain numerous noncollagenous proteins called NCPs. On the basis of mutation 
experiments and suppression of NCP genes, it is suggested that they stimulate the 
nucleation and growth of hydroxyapatite crystals [112].
Bones and dentin differ significantly. Bone is a dynamic tissue because it is 
constantly remodeled, while dentin is a rather static tissue [112]. Osteoblasts 
produce matrix components as a result of controlling growth factors to form a bone. 
Hydroxyapatite crystals grow above vesicles, thus creating mineralization centers. 
Bones have a lot of vessels, and they store calcium ions. The reason for bone resorp-
tion is the action of lysosomal enzymes produced by osteoclasts and lowering the 
pH in extracellular bone matrix.
Osteoclasts are responsible for the attachment, bone degradation, and subse-
quent tissue resorption. It was found that this is possible due to the strong polariza-
tion of osteoclasts. They have both frontal and posterior abdominal polarization. 
On the underside of the osteoclasts, there are structures responsible for the deg-
radation of the mineral surface. The adhesion zone is located in the sealing zone 
[114]—a ring made of actin and podosomes in which extracellular resorption pit is 
segregated and is used to retain heavy substances (minerals) formed during bone 
resorption near the bone surface [43, 114]. Podosomes are dynamic structures built 
of actin. They perform important functions, including adhesion, destruction of the 
bone and its matrix, and recognition of the appropriate medium [115]. Podosomes 
contain a large number of V-ATPase molecules that pump protons and secrete prote-
ases, which promote bone degradation [114].
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